Guowen Wang, n/a

Bone Cancer Department, TMUCIH - Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin, China (People's Republic)

Presentation(s):

• Paper 07 - ARTEMIS-002: A PHASE 2 STUDY OF HS-20093 IN PATIENTS WITH RELAPSED OR REFRACTORY SARCOMAS

  Thursday, November 13, 2025
  11:30 AM - 12:30 PM EST

  Disclosure information not submitted.

• Paper 10 - TQB2928, A NOVEL ANTI-CD47 MONOCLONAL ANTIBODY, IN COMBINATION WITH ANLOTINIB FOR THE TREATMENT OF RECURRENT/METASTATIC OSTEOSARCOMA: A PHASE 1B STUDY

  Thursday, November 13, 2025
  11:30 AM - 12:30 PM EST

  Disclosure information not submitted.